China mulls mixing vaccines to improve efficacy of jabs | Daily News

China mulls mixing vaccines to improve efficacy of jabs

Work at a factory of Chinese vaccine maker Sinovac Biotech in Beijing.
Work at a factory of Chinese vaccine maker Sinovac Biotech in Beijing.

CHINA: China is considering the mixing of different COVID-19 vaccines to improve the relatively low efficacy of its existing options, a top health expert has told a conference.

Authorities have to "consider ways to solve the issue that efficacy rates of existing vaccines are not high", Chinese media outlet The Paper reported, citing Gao Fu, the head of the Center for Disease Control and Prevention.

His comments mark the first time a top Chinese expert has publicly alluded to the relatively low efficacy of the country's vaccines, as China forges ahead in its mass vaccination campaign and exports its jabs around the world.

China has administered around 161 million doses since vaccinations began last year -- most people will require two shots -- and aims to fully inoculate 40 percent of its 1.4 billion population by June.

But many have been slow to sign up for jabs, with life largely back to normal within China's borders and domestic outbreaks under control.

Gao has previously stressed the best way to prevent the spread of Covid-19 is vaccination, and said in a recent state media interview that China aims to vaccinate 70 percent to 80 percent of its population between the end of this year and mid-2022.

At the conference in Chengdu on Saturday, Gao added that an option to overcome the efficacy problem is to alternate the use of vaccine doses that tap different technologies.

This is an option that health experts outside China are studying as well.

Gao said experts should not ignore mRNA vaccines just because there are already several coronavirus jabs in the country, urging for further development, The Paper reported.

Sinopharm's vaccines have efficacy rates of 79.34 percent and 72.51 percent respectively, while the overall efficacy for CanSino's stands at 65.28 percent after 28 days.

Venezuela to produce Cuban COVID-19 vaccine

Venezuela hopes to produce two million doses per month of a Cuban coronavirus vaccine, President Nicolas Maduro said Sunday.

The South American country will also take part in Phase 3 trials for the Abdala vaccine produced by its socialist ally. "We've signed an agreement to produce in our laboratories... two million vaccines a month of the Abdala vaccine... for August, September, approximately," said Maduro in a television address.

Cuba has developed four vaccines that are in various stages of clinical trials.

Germany's COVID-19 infections pass 3 m

The number of COVID-19 infections in Germany has crossed the three million mark, according to figures published Monday by the Robert Koch Institute disease control centre.

The total number of infections now stands at 3,011,513, with 78,452 deaths, the institute said.

China gives 200,000 vaccine doses to Cameroon

Cameroon received a gift of 200,000 doses of China's Sinopharm vaccine against Covid-19 on Sunday, state television reported.

The country of around 26 million people is one of the hardest hit on the African continent, with 61,700 cases and 919 deaths recorded. Neighbours Equatorial Guinea and Gabon have already begun inoculation campaigns using the Sinopharm vaccine. - AFP